Abstract Body

Recent studies have demonstrated that up to 40% of women are lost to follow-up after initiating antiretroviral therapy (ART) during pregnancy in Option B+ programs. Data are limited on long-term virologic outcomes and retention in care, particularly after cessation of breastfeeding.

We evaluated retention in care and viral suppression (VS) 2-5 years postpartum among previously ART-naïve women who initiated ART during pregnancy (Option B+) at 12-28 weeks gestation in a study (PROMOTE, NCT00993031) in rural Uganda. Participants breastfed and were followed for up to 1 year postpartum, then referred to clinics in surrounding communities. A random sample (n=200) was invited to participate in a cross-sectional follow-up study after completing the trial, including a questionnaire and pregnancy and HIV viral load (VL) testing. Retention in care was defined as having attended an HIV clinic in the last 90 days. Logistic regression models were used to examine factors associated with VS (VL ≤400 copies/ml).

One hundred fifty women (75%) were successfully contacted for follow-up. Median months postpartum was 46 (IQR 37-52) and median CD4 count was 664 cells/mm3 (IQR 476-870). Of the 150 contacted, 131 (87.3%) were on ART (78 on EFV, 35 on NVP, 18 on LPV). Fifty-eight (38.7%) participants reported ≥1 pregnancy after initiating Option B+; 19 (12.7%) were pregnant at the time of follow-up and 23 (15.3%) were breastfeeding. Long-term retention in care following initiation of Option B+ was 90% (95% CI 84.0%-94.3%), with 135/150 seen in the last 90 days. Assuming those we could not contact had fallen out of care (n=50), retention in care was 67.5% (95% CI 60.5%-73.9%). Among the 150 contacted, 121 (80.7%, 95% CI 73.4%-86.7%) had VS. Assuming those we could not contact had virologic failure, long-term retention in care with VS was 60.5% (95% CI 53.6%-67.3%). Factors associated with VS included disclosure of HIV status to primary partner (OR 5.24, 95% CI 1.21-22.6), no difficulty obtaining ART in the past 3 months (OR 4.16, 95% CI 1.50-11.5), and food security (OR 2.61, 95% CI 1.00-6.88).

Following initiation of Option-B+, long-term (2-5 year) retention in care and viral suppression was observed in 90% and 80.7%, respectively. Women who had disclosed their HIV status to their primary partner were 5 times more likely to be virologically suppressed, indicating a significant need for facilitated disclosure interventions to maintain long-term retention in care with viral suppression.